Argus Research Downgrades Zions Bancorp to Hold
Portfolio Pulse from Benzinga Newsdesk
Argus Research analyst Kevin Heal has downgraded Zions Bancorp (NASDAQ:ZION) from Buy to Hold.

July 25, 2024 | 11:51 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Argus Research analyst Kevin Heal has downgraded Zions Bancorp from Buy to Hold, indicating a less optimistic outlook on the stock.
The downgrade from Buy to Hold by a reputable analyst suggests a less favorable view on Zions Bancorp's future performance, which could lead to a short-term decline in the stock price as investors react to the news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100